Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2022]
Author:  Saad, Everardo D.

Results 1-6 of 6 (Search time: 0.001 seconds).

Issue DateTitleContributor(s)TypeCat.
12022Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyGoldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, AimeryJournal ContributionA1
22022Surrogacy Beyond Prognosis: The Importance of “Trial-Level” SurrogacyBUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S.Journal ContributionA1
32021The Net Benefit of a treatment should take the correlation between benefits and harms into accountBUYSE, Marc; Saad, Everardo D.; Peron, Julien; Chiem, Jean-Christophe; De Backer, Mickael; Cantagallo, Eva; Ciani, OrianaJournal ContributionA1
42020Commentary on Bamat et alSaad, Everardo D.; BUYSE, MarcJournal ContributionA2
52020Central statistical monitoring of investigator-led clinical trials in oncologyBUYSE, Marc; Trotta, Laura; Saad, Everardo D.; Sakamoto, JunichiJournal ContributionA1
62020Statistical aspects in adjuvant and neoadjuvant trials for gastrointestinal cancer in 2020: focus on time-to-event endpointsSaad, Everardo D.; BUYSE, MarcJournal ContributionA1